MUC1 and thymus lymphoma: Moreover, recombinant fusion protein of HSP65 BCG plus a variable-number tandem repeats of MUC1, inoculated both as preventive and therapeutic treatment in mice, inhibits EL4 thymus lymphoma MUC1-expressing EL4 thymus lymphoma tumors and significantly prolonged the survival compared to non-vaccinated tumor-bearing mice [56].